explore -WSS

explore

author：Wikipedia 2025-09-05 11:30:16 - browse：7836

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Why we need mandatory labeling of GMO products

entertainment

knowledge

entertainment

WSS

Surprise medical billing ban raises prices elsewhere

Medical students need to learn the potent medicine of empathy

Reporting on presidential health from Reagan to Trump and Biden

Weight loss drugs aren’t covered by Obamacare. That may change

As AI regulations shape up, health tech startups beg for clarity

Measles policy set amid Florida outbreak alarms vaccine proponents

explore

explore

leisure time

New air purifier tech could be key to improving indoor air quality

Louisiana bill approved classifying abortion pills as controlled substances

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New study raises questions about niacin and heart health

Virginia high school admissions case could be legal follow

Medicare Advantage enrollment hits roughly 33.4 million

Continuity nursing helped my family in our darkest PICU moments

Abridge raises $150m as clinical notes automation market heats up

Walensky prepares to leave CDC — and Congress — behind

Reporting on presidential health from Reagan to Trump and Biden

leisure time

Clinicians often fail to acknowledge the pain caused by long Covid

MD Anderson's Padmanee Sharma responds to research credit suit

Weight loss drugs aren’t covered by Obamacare. That may change

A new drug could help frostbite victims avoid its ravages

New study raises questions about niacin and heart health

A new drug could help frostbite victims avoid its ravages

entertainment

knowledge

entertainment

Wikipedia